Petros Pharmaceuticals, Inc. Dividends, Preferred Stock
Petros Pharmaceuticals, Inc. (PTPI) reported Dividends, Preferred Stock of $453.36 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Shareholders' Equity
us-gaap:DividendsPreferredStock · last filed 2024-11-13
- Petros Pharmaceuticals, Inc. dividends, preferred stock for the quarter ending 2024-09-30 was $453.36K.
- Petros Pharmaceuticals, Inc. dividends, preferred stock for the quarter ending 2024-06-30 was $216.80K.
| Period end | Dividends, Preferred Stock 3 month | Dividends, Preferred Stock 6 month | Dividends, Preferred Stock 9 month |
|---|---|---|---|
| 2024-09-30 | $453.36K 10-Q · filed 2024-11-13 | $670.16K derived: sum of 2 quarters · filed 2024-11-13 | $1.27M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $216.80K 10-Q · filed 2024-08-14 | $812.30K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |